Unknown

Dataset Information

0

Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants.


ABSTRACT: QS-7-Api is an exceedingly potent immuno-adjuvant isolated from the bark of Quillaja saponaria. It is significantly less toxic than QS-21, a related saponin that is currently the favored adjuvant in anticancer and antiviral vaccine clinical trials. Tedious isolation/purification protocols and uncertainty in its structural constitution have hindered the clinical development of QS-7. A chemical synthesis of QS-7-Api is described, providing structural verification of the adjuvant. A novel semisynthetic sequence to QS-7-Api has also been established, greatly facilitating access to QS-7 for preclinical and clinical evaluation.

SUBMITTER: Deng K 

PROVIDER: S-EPMC2610460 | biostudies-literature | 2008 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants.

Deng Kai K   Adams Michelle M MM   Gin David Y DY  

Journal of the American Chemical Society 20080415 18


QS-7-Api is an exceedingly potent immuno-adjuvant isolated from the bark of Quillaja saponaria. It is significantly less toxic than QS-21, a related saponin that is currently the favored adjuvant in anticancer and antiviral vaccine clinical trials. Tedious isolation/purification protocols and uncertainty in its structural constitution have hindered the clinical development of QS-7. A chemical synthesis of QS-7-Api is described, providing structural verification of the adjuvant. A novel semisynth  ...[more]

Similar Datasets

| S-EPMC2615099 | biostudies-literature
| PRJNA488309 | ENA
| S-EPMC7324585 | biostudies-literature
| S-EPMC4813187 | biostudies-literature
| S-EPMC4435470 | biostudies-literature
| S-EPMC3658151 | biostudies-literature
| PRJNA914519 | ENA
| PRJNA487056 | ENA
| S-EPMC9321238 | biostudies-literature